Zoladex
Active Ingredient(s): GoserelinFDA Approved: * December 29, 1989
Pharm Company: * ASTRAZENECA
Category: Cancer
Goserelin, sold under the brand name Zoladex among others, is a medication which is used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer.[1][2] It is an injectable gonadotropin releasing hormone agonist (GnRH agonist). Structurally, it is a decapeptide. It is the natural GnRH decapeptide with two substitutions to inhibit rapid degradation. Goserelin stimulates the production of ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.